Seroprevalence of infection by syphilis, HIV 1/2, toxoplasmosis, hepatitis B and hepatitis C in pregnant women assisted by the health service of Penedo-AL | Zendy

Natália Tenório de Mendonça Uchôa | Zendy; Karwhory Wallas Lins da Silva | Zendy; P. V. M. Azevedo | Zendy; Thiago José Matos Rocha | Zendy; Erlon Oliveira dos Santos | Zendy; Flaviana Santos Wanderley | Zendy

Open Access

Seroprevalence of infection by syphilis, HIV 1/2, toxoplasmosis, hepatitis B and hepatitis C in pregnant women assisted by the health service of Penedo-AL

Author(s) -

Natália Tenório de Mendonça Uchôa,

Karwhory Wallas Lins da Silva,

P. V. M. Azevedo,

Thiago José Matos Rocha,

Erlon Oliveira dos Santos,

Flaviana Santos Wanderley

Publication year - 2022

Publication title -

research society and development

Language(s) - English

Resource type - Journals

ISSN - 2525-3409

DOI - 10.33448/rsd-v11i5.21158

Subject(s) - syphilis , medicine , toxoplasmosis , seroprevalence , hepatitis , transmission (telecommunications) , hepatitis b , pregnancy , obstetrics , immunology , pediatrics , human immunodeficiency virus (hiv) , antibody , serology , biology , electrical engineering , genetics , engineering

Infections during pregnancy are frequent and can cause severe complications, affecting the maternal-fetal binomial. Prenatal care is a classic example of prevention. A cross-sectional study was conducted with pregnant women to analyze the results of the nontreponemal test for syphilis and serologies for HIV 1/2, toxoplasmosis (IgM and IgG), hepatitis B and hepatitis C. The prevalences found were 4.9% (20/408), 0.24% (1/408), 20.83% (85/408), 0.49% (2/408), respectively for syphilis, HIV ½, toxoplasmosis (IgG) and HBV. No case of infection by the hepatitis C virus and acute toxoplasmosis (IgM) has been identified. It was possible to observe a high prevalence of syphilis, while the remaining infections had low prevalence. Screening for these infections is extremely important for the early diagnosis and treatment of pregnant women, avoiding maternal-fetal transmission and enabling better strategic planning for the prevention and early treatment of pregnant women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research